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In 2004, health-care providers in the United States consumed $US1.9 trillion, or about 16% of the gross 
domestic product. By 2010, the cost of 
health care is predicted to exceed 20% 
of the US gross domestic product [1]. 
The management of chronic diseases 
currently accounts for 70%–75% of 
health-care spending [2], and this 
proportion is likely to increase in the 
future. Unlike acute illness, chronic 
illness requires continuous and 
sometimes complex management over 
prolonged periods of time, with the 
goal of improving or stabilizing quality 
of life.
One of the proposals for reducing 
the costs and improving the quality of 
chronic care is for patients to become 
their own providers of medical care 
[2]. Empirical studies of a number of 
chronic diseases support the feasibility 
of such a proposal [3–5]. Such studies 
found that self-management produced 
higher quality outcomes at lower costs 
than conventional models of care.
Self-management is deﬁ ned as: (1) 
engaging in activities that protect 
and promote health; (2) monitoring 
and managing symptoms and signs 
of illness; (3) managing the impacts 
of illness on function, emotions, and 
interpersonal relationships; and (4) 
adhering to treatment regimens [6]. In 
this Essay, we consider the advantages 
and limitations of self-management 
tools.
“Toolkits” for Patient 
Self-Management
Researchers in the ﬁ eld of innovation 
management have coined the term 
“user innovation toolkits” to refer to 
integrated sets of specialized tools that 
enable end users of a product or service 
to develop or modify products for 
themselves [7]. For example, toolkits 
can enable non-specialists to develop 
custom products including complicated 
integrated electrical circuits for 
themselves, without any assistance from 
factory experts. The shifting of product 
and service development tasks to the 
consumer is a major trend in many 
ﬁ elds today, because it cuts costs while 
at the same time increasing quality 
of, and user satisfaction with, the new 
product [8,9].
Shifting a problem-solving task to 
users via a toolkit lowers costs when 
users possess the information required 
to solve the problem in raw form—and 
when it is cheaper to transfer the tools 
needed to process that information to 
the user than it is to transfer the user’s 
information to an expert.
This same economic logic can be 
applied to medical toolkits devised 
for a speciﬁ c purpose—patient self-
management of chronic medical 
conditions. Such toolkits offer patients 
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Figure 1. An Example of a Toolkit for All Literacy Level Patients with Congestive Heart Failure
Adapted from [19].
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the tools needed to enable them to 
process their personal “raw” disease-
related data into information that helps 
them manage their own illness. The 
toolkit gives patients the information 
needed to: (1) appropriately recognize 
when to apply a prescribed or over-the-
counter medical treatment; (2) apply 
the treatment; (3) receive feedback 
on the results of the treatment; and 
(4) make appropriate treatment 
adjustments without the involvement of 
a health-care specialist.
Several patient self-management 
tools are already in use [10], such as in 
the management of patients with type 
1 diabetes. After diagnosis, physicians 
generally supply patients with a toolkit 
for diabetes self-management. In other 
words, patients are: (1) supplied with 
and taught to use a blood glucose 
monitor to determine their blood 
sugar level; (2) taught how to apply 
the treatment they need (via self-
injection of insulin for elevated blood 
glucose levels or oral sugar for low 
blood glucose levels); (3) taught how 
to get feedback on the results of their 
treatment action (again via a blood 
glucose meter); and (4) taught how to 
correct and improve their disease self-
management activities based upon this 
feedback. Studies have shown a low rate 
of adverse events related to diabetes 
self-management [11–13]. Clinician 
support for patient self-management 
appears to be an important predictor 
of the quality of clinical outcomes in 
patients with diabetes [14].
Compare and contrast this toolkit 
model of diabetes self-care with 
the conventional management of 
hypertension. Despite the fact that 
home blood pressure monitoring is 
readily available and the drugs used to 
treat hypertension have a wide margin 
of safety, most patients repeatedly visit 
their health-care provider for routine 
blood pressure monitoring and routine 
drug dosage adjustments. And yet 
home monitoring has been shown to 
improve blood pressure reductions and 
adherence to medication [15].
Why is there a disparity in the 
management of these two chronic 
diseases? In the case of type 1 diabetes, 
simple logic suggests that there is 
no other way to manage the disease. 
Patients must be involved in self-
management due to the nature of 
the illness and the need for timely 
self-administered treatment. However, 
the pharmacologic treatment of 
hypertension allows the health-care 
delivery system to supply adequate 
treatment via a conventional 
relationship between health 
professional and patient.
Self-Management Toolkits 
Are Technically Feasible
What factors are important for 
successful self-management of a 
chronic illness? The ﬁ rst is showing 
patients how to self-administer 
standard evaluation scales or perform 
simple assessments that are currently 
administered by health professionals.
The second factor is pre-prescription 
of medicine and dosage adjustments 
based on speciﬁ c assessment results. 
Individual doctors currently apply 
such dosage adjustments in a routine 
manner for most of their patients 
given speciﬁ ed assessment results. For 
example, adjustment of medication for 
depression is often accomplished by 
means of a questionnaire administered 
by health-care professionals. 
This method is routinely used in 
randomized clinical trails [16,17]. 
Given speciﬁ c reassessment results, 
many specialists have a standard 
“next step adjustment” in dosages 
or medications that they routinely 
apply for most of their patients. It may 
thus be feasible to give patients with 
depression a self-management toolkit 
involving: (1) a questionnaire that 
allows them to assess the severity of 
their illness and (2) a pre-prescribed 
plan for adjusting the dosage in 
response to results of the assessment.
In the case of most medications, 
optimal dosages vary from patient to 
patient and, for a speciﬁ c patient, may 
also vary over time and according to 
variations in living conditions. The 
use of toolkits allows a process of trial 
and error as users modify their actions 
based on experience and feedback. As 
each user iterates, he or she can move 
towards the optimal dosage for their 
speciﬁ c circumstances. Toolkits must 
be designed to support this range of 
user experimentation while at the same 
time indicating areas of danger.
There are data that suggest a well-
designed toolkit may well reduce risks 
as compared to conventional care even 
in patients with low literacy [18,19]. 
Figure 1 is an excellent example of 
such a toolkit [19]. The toolkit allows 
patients to adjust their medication 
based on a systematic trial and error 
method. A critical element to this 
process is feedback. In this case, daily 
weights are used to adjust the dose of 
diuretic. This level of control would not 
be possible without the use of either 
the toolkit or the daily interaction with 
a health-care professional.
A research program to develop self-
management tools, and to make them 
available as appropriate, must build 
on our existing knowledge of patient 
adherence to treatment. For example, 
patients are more likely to comply 
with a practitioner’s instructions to 
take medicines as instructed when 
the patients can observe the impact 
of their behaviors [18–20]. Toolkits, 
with their feedback component, can 
be expected to improve adherence to 
a prescribed medication plan. Indeed 
self-management tools have been used 
to improve adherence to medication in 
patients with asthma [21].
Why Have Toolkits Not Become 
Commonplace?
When chronic disease management 
becomes routine, as in the 
management of type 1 diabetes, it 
often becomes technically possible 
to shift management by professionals 
to self-care by patients equipped 
with appropriate tools and training. 
But even when such a shift becomes 
technically possible, there tends to be 
a lag in actually moving towards self-
management. In good part this lag can 
be understood by considering what 
needs to happen at the level of health-
care delivery systems for a change to 
occur.
Consider, for example, the use 
of anticoagulants on an outpatient 
basis. Several large clinical trails have 
shown that patient self-management 
(including home determination of the 
degree of anticoagulation and dosage 
adjustments) is as good as, if not better 
than, the care provided in specialized 
anticoagulation clinics [22,23]. 
In addition, self-management is 
signiﬁ cantly less costly to medical care 
insurance providers [24]. Indeed, both 
of these outcomes have been shown in 
large-scale practice in Germany, where 
anticoagulation self-management is 
now a routine practice [24,25].
Despite this evidence of better 
outcomes at lower costs via patient self-
care, a recent survey of anticoagulation 
practitioners in the US indicated that 
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only 1% of US patients on long-term 
anticoagulation regimens are involved 
in self-testing [26]. In fact, 60% of the 
specialist care providers who responded 
to the survey noted that patient self-
care is speciﬁ cally prohibited by the 
specialist’s policies [26].
This situation is understandable 
when you consider that care provision 
systems designed around what was 
best practice in earlier days may well 
suffer a loss of business if they adopt 
newer practices. In addition, toolkits 
by their very nature tend to alter the 
conventional relationships between 
health professionals and patients, 
which could lead to professionals losing 
their status or even their jobs. The 
introduction of toolkits may therefore 
understandably be resisted unless they 
are introduced with sensitivity to these 
issues [27].
Limitations and Recommendations
While self-management tools appear 
to have potential ﬁ nancial and clinical 
beneﬁ ts, they also have limitations. 
By deﬁ nition, toolkits can only be 
applied in situations where there is 
a clear and unambiguous feedback 
mechanism for patients. This feedback 
may take the form of a measurable 
symptom or a physiologic variable 
that is easy to monitor. To reduce the 
health risks associated with self-care, 
well-designed toolkits must allow the 
layperson to perform medical tasks at 
a level of sophistication nearly that of 
the expert. Although this might appear 
to be an impossible task, it has been 
achieved in many ﬁ elds of medicine. 
For example, at least one recent review 
of evidence-based practices noted 
the value of patient self-management 
of anticoagulants as a risk reduction 
strategy [28].
We propose that the time has 
come for health systems to support 
appropriate and appropriately timed 
shifts from practitioner-based care 
to patient self-management. The 
use of toolkits in other ﬁ elds has 
demonstrated an improvement in 
quality, lowering of costs, and more 
efﬁ cient completion of tasks. This 
trend holds even in very complex ﬁ elds. 
We believe that this trend will also be 
evident in the management of patients 
with chronic illness. 
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